Pozen wins court battle over migraine drug - Triangle Business Journal

A federal court has found in favor of Pozen Inc. in the Chapel Hill company’s patent fight with three generic drug companies. The U.S. District Court for the Eastern District of Texas found that three patents held by Pozen (Nasdaq: POZN) were valid and were infringed by Woodcliff Lake, N.J.-based Par Pharmaceutical Inc . and Indian drug company Dr. Reddy’s Laboratories Inc. A third firm, Australian company Alphapharm Pty Ltd., was found to have...